Delivery Order SPE2DB22D1106-SPE2DB25FFFS9
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $6,584.70 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 ml pen injections (0.5 ml units) on August 21, 2025, with completion expected by August 22, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a single transaction under a larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pen injections in 0.5 ml doses, valued at $10,714.36. This is a firm fixed-price delivery order with an ultimate completion date of July 29, 2025, with performance taking place at the vendor's facility in Conshohocken, Pennsylvania. The contract was competitively awarded without set-aside designation, reflecting AmerisourceBergen's established...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pen injections with a ceiling value of $2,252.25. This non-competitive delivery order, utilizing firm fixed pricing, represents a discrete pharmaceutical procurement under AmerisourceBergen's broader relationship with DLA. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania, with an ultimate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 ml pen injections valued at $1,744.44 under a firm fixed-price contract type. This non-set-aside award was issued on December 11, 2025, with an ultimate completion date of December 12, 2025. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, the location of AmerisourceBergen's corporate office and primary distribution hub for federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $1,502.55 to AmerisourceBergen Drug Corp for the supply of Trulicity 4.5 mg/0.5 ml pen injectors on October 24, 2025, with completion expected by October 27, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded under an existing indefinite delivery contract. The product will be delivered to the Place of Performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- The Defense Logistics Agency awarded a $2,548.11 delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pen auto-injectors in 0.5 ml dosage units. This is a firm fixed-price, competitively awarded contract with an ultimate completion date of August 18, 2025, and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. No set-aside provisions were applied to this procurement. This delivery order is issued...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,351.35 to AmerisourceBergen Drug Corp for the supply of Trulicity 4.5 mg/0.5 ml pen injectors on July 18, 2025. This firm fixed-price delivery order, with an ultimate completion date of July 21, 2025, represents a competitively awarded contract with no set-aside designation. The products will be delivered to Conshohocken, Pennsylvania, the location of AmerisourceBergen's corporate headquarters and primary operations center....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pen injectors, with a ceiling value of $1,801.80 and an ultimate completion date of September 16, 2025. This is a firm fixed-price delivery order with no set-aside designation, meaning it was competitively awarded. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,277.30 for Trulicity 1.5 mg/0.5 mL pen injections on April 24, 2025, with an ultimate completion date of April 25, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under AmerisourceBergen's existing pharmaceutical supply contract vehicle. The product will be delivered to the company's facility in Conshohocken, Pennsylvania, where AmerisourceBergen...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 ml pen injections with a ceiling value of $1,183.02. This competitively awarded, firm fixed-price delivery order was issued on November 20, 2025, with an ultimate completion date of November 21, 2025. The contract represents a continuation of AmerisourceBergen's pharmaceutical supply services under its larger Indefinite Delivery Contract vehicle with DLA Troop Support...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FFFS9Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,702.70 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pen injections (0.5 mL quantity). This is a firm fixed price, competitively awarded contract with no set-aside designation, due for completion by August 28, 2025. The award was issued on August 27, 2025, with performance to be executed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. That prime vehicle serves as a comprehensive global pharmaceutical support agreement enabling AmerisourceBergen to supply a broad range of pharmaceutical products, medical supplies, vaccines, and specialty medications to support military healthcare programs and the Defense Health Agency. The current delivery order for Trulicity, a diabetes medication, exemplifies the routine pharmaceutical procurement executed under this expansive contract framework designed to support federal medical supply chain requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.7k | 8/27/25 |